跳至主要内容
临床试验/JPRN-UMIN000004100
JPRN-UMIN000004100已完成1 期

Phase I study of stereotactic body radiation therapy (SBRT) for stage IA, centrally located non-small cell lung cancer - Phase I study of SBRT for stage IA, centrally located non-small cell lung cancer

Japanese Radiation Oncology Study Group(JROSG)0 个研究点目标入组 30 人开始时间: 2010年8月25日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Prior invasive malignancy unless disease free for a minimum of 3 years (e.g., carcinomas in situ, T1N0M0 laryngeal cancer, low risk prostate cancer;T1-2a and Gleason score 2-6 an dPSA < 10 ng/ml, stage I breast, and cancers which can expect long survalval as well as these cancers are permissible) 2)Prior radiotherapy to the region of the study cancer that would result in overlap of radiationtherapy fields; 3) Obvious interstitial pnumonitis or fibrosis on chest X-ray 4) Active infection 5)Women of childbearing potential and male participants must agree to use a medically effective means of birth control throughout their participation in the treatment phase of the study 6) patients who are judged to be imppsible to participate this study due to psycologic disease

研究者

发起方
Japanese Radiation Oncology Study Group(JROSG)

相似试验

Phase I study of stereotactic body radiation therapy... | 临床试验